ArticleJournal for immunotherapy of cancer2025

TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplant.

Aicha E Quamine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.